IDiyas

For the Inventor, By the Inventor

Waterford, CT, United States of America

Fredric J Vinick

USPTO Granted Patents = 12

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Waterford, CT (US) (1980 - 1998)
  • Winchester, MA (US) (1999)

Company Filing History:

goldMedal12 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1980-1999

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5859011 - Dihydropyridine derivatives as bradykinin antagonist (1999-01-12),
2. 5847155 - Aromatic pyrrolidine amide prolyl endopeptidase inhibitors (1998-12-08),
3. 5459145 - Calcium independent camp phosphodiesterase inhibitor antidepressant (1995-10-17),
4. 5414127 - Calcium independent camp phosphodiesterase inhibitor antidepressant (1995-05-09),
5. 5294730 - Calcium independent camp phosphodiesterase inhibitor antidepressant (1994-03-15),
6. 5196426 - Calcium independent C amp phosphodiesterase inhibitor antidepressant (1993-03-23),
7. 5128358 - Aryl substituted nitrogen heterocyclic antidepressants (1992-07-07),
8. 4861891 - Antidepressant N-substituted nicotinamide compounds (1989-08-29),
9. 4359416 - Process for preparing L-carnosine (1982-11-16),
10. 4321391 - Preparation of L-aspartic acid N-thiocarboxyanhydride (1982-03-23),
11. 4256897 - Process for the preparation of L-aspartic acid N-thiocarboxyanhydride (1981-03-17),
12. 4238392 - Purification of L-aspartyl-L-phenylalanine alkyl esters (1980-12-09),

Title: Fredric J Vinick: Innovator in Pharmaceutical Research

Introduction

Fredric J Vinick, an inventive mind based in Waterford, Connecticut, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 12 patents, he has focused on developing innovative compounds aimed at treating complex health conditions.

Latest Patents

Among his notable inventions are patents for dihydropyridine derivatives serving as bradykinin antagonists, as well as aromatic pyrrolidine amide prolyl endopeptidase inhibitors. His research has led to the creation of a series of aromatic pyrrolidine derivatives and their suitable pharmaceutically acceptable salts, which are poised to be useful as PEP inhibitors in treating Alzheimer's disease, amnesia, dementia, anxiety, ischemia, and stroke.

Career Highlights

Fredric is currently employed at Pfizer Corporation, a leader in biopharmaceuticals, where he has furthered his research and development efforts. His career is characterized by a commitment to advancing medical science through innovation, ensuring that patients receive effective treatments for debilitating conditions.

Collaborations

In his work, Fredric Vinick has collaborated with esteemed colleagues, including Nicholas A Saccomano and W Stephen Faraci. Together, they have cultivated an environment of creativity and expertise that fosters groundbreaking advancements in pharmaceutical research.

Conclusion

Fredric J Vinick’s contributions to the field through his patents highlight the essential role of inventors in developing innovative solutions for healthcare challenges. His dedication to research at Pfizer Corporation demonstrates a profound impact on the future of medicine, providing hope for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…